Artemether/hydroxypropyl-β-cyclodextrin host-guest system: Characterization, phase-solubility and inclusion mode

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 17, 2009, Pages 6311-6317

  Yang, Bo ^a,b   Lin, Jun ^a   Chen, Yong ^b   Liu, Yu ^b  

^a YUNNAN UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Artemether; Characterization; Hydroxypropyl cyclodextrin; Inclusion mode; Phase solubility

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ARTEMETHER; METHYL GROUP;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SOLUBILITY; DRUG SYNTHESIS; MALE; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; ROTATING FRAME OVERHAUSER EFFECT SPECTROSCOPY; SPECTROSCOPY; THERMAL ANALYSIS; X RAY POWDER DIFFRACTION;

ANIMALS; ANTIMALARIALS; ARTEMISININS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; MAGNETIC RESONANCE SPECTROSCOPY; RATS; SOLUBILITY; X-RAY DIFFRACTION;

EID: 68649127581     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.07.060     Document Type: Article

References (28)

1. Jomaa H., Wiesner J., Sanderbrand S., Altincicek B., Weidemeyer C., Hintz M., Tübachova I., Eberl M., Zeider J., Liechtenthaler H.K., Soldati D., and Beck E. Science 285 (1999) 1573
2. O'Neill P.M., Pugh M., Stachulski A.V., Ward S.A., Davies J., and Park B.K. J. Chem. Soc. Perkin Trans. 1 (2001) 2682
3. Foley M., and Tilley L. Int. J. Parasitol. 27 (1997) 213
4. Klayman D. Science 228 (1985) 1049
5. WHO. In The Use of Artemisinin and its Derivatives as Anti-malarial Drugs. Report of a Joint CTD/DMP/TDR Informal Consultation, World Health Organization: Geneva, 1998.
6. Bailint G.A. Pharma. Therap. 90 (2001) 261
7. WHO. In Guidelines for the Treatment of Malaria, World Health Organization: Switzerland, 2006.
8. Baker J.K., Yarber R.H., Hufford C.D., ILee S., Elsohly H.N., and McChesney J.D. Biomed. Environ. Mass Spectrom. 18 (1988) 337
9. Maggs J.L., Bishop L.P.D., Edwards G., O'Neill P.M., Ward S.A., Winstanley P.A., and Park B.K. Drug Metab. Dispos. 28 (2000) 209
10. Szejtli J. Cyclodextrin Technology (1988), Kluwer Academic, Dordrecht
11. Uekama K., Hirayama F., and Irie T. Chem. Rev. 98 (1998) 2045
12. Loftsson T., and Järvinen T. Adv. Drug Delivery Rev. 36 (1999) 59
13. Loftsson T., and Brewster M.E. J. Pharm. Sci. 85 (1996) 1017
14. Gould S., and Scott R.C. Food Chem. Toxicol. 43 (2005) 1451
15. Castronuovo G., and Niccoli M. Bioorg. Med. Chem. 14 (2006) 3883
16. Brewster M.E., and Loftsson T. Pharmazie 57 (2002) 94
17. Duchene D., Wouessidjewe D., and Poncel G. J. Controlled Release 62 (1999) 263
18. Irie T., and Uekama K. J. Pharm. Sci. 86 (1997) 147
19. Davis M.E., and Brewster M.E. Nat. Rev. Drug Discovery 3 (2004) 1023
20. Ansari M.T., Iqbal I., and Sunderland V.B. Arch. Pharm. Res. 32 (2009) 155
21. Higuchi T., and Connors K.A. Adv. Anal. Chem. Instrum. 4 (1965) 117
22. Hu H.-Y., and Zhang Z.-R. HECHENG HUAXUE 7 (1999) 334
23. Loftsson T., Hreinsdóttir D., and Masson M. Int. J. Pharm. 302 (2005) 18
24. Liu Y., Chen C.-S., Chen Y., and Lin J. Bioorg. Med. Chem. 13 (2005) 4037
25. de Araújo M.V.G., Vieira E.K.B., Lázaro G.S., Conegero L.S., Almeida L.E., Barreto L.S., da Costa N.B., and Gimeneza I.F. Bioorg. Med. Chem. 16 (2008) 5788
26. Correia I., Bezzenine N., Ronzani N., Platzer N., Beloeil J.-C., and Doan B.-T. J. Phys. Org. Chem. 15 (2002) 647
27. Araujo M.V.G., Vieira E.K.B., Lazaro G.S., Conegero L.S., Ferreira O.P., Almeida L.E., Barreto L.S., Costa Jr. N.B., and Gimenez I.F. Bioorg. Med. Chem. 15 (2007) 5752
28. Cao F., Guo J.-X., Ping Q.-N., and Liao Z.-G. Eur. J. Pharm. Sci. 29 (2006) 385